Ascendis Pharma A ASND
NASDAQ ASND
$228.07 -1.98 (-0.86%)
At close: Sep 29, 2026 · 4:00 PM EDT

Ascendis Pharma A (ASND) Total Liabilities (2012 - 2026)

Updated

Ascendis Pharma A (ASND) posted Total Liabilities of $987.46 million for the quarter ended Jun 30, 2026, down 31.6% from $1.44 billion a year earlier and down 44.3% from the prior quarter.

Analysis

Ascendis Pharma A (ASND) Total Liabilities (2012 - 2026) Analysis & Trends

As of Dec 31, 2025, Ascendis Pharma A's Total Liabilities came in at $1.66 billion, down 52.9% from the prior year.

  • Annual Total Liabilities shows a five-year compound annual growth rate of 12.3% (years ended Dec 2020 to Dec 2025).
  • In prior years, Ascendis Pharma A's Total Liabilities was $3.52 billion in the year ended Dec 31, 2024 (+234.9%), $1.05 billion in the year ended Dec 31, 2023 (+20.6%), $870.98 million in the year ended Dec 31, 2022 (-31.7%) and $1.27 billion in the year ended Dec 31, 2021 (+37.5%).
  • The figure for the quarter ended Jun 30, 2026 stands as the lowest quarterly Total Liabilities since the quarter ended Jun 30, 2023.
  • On a year-over-year basis, Total Liabilities increased in six of the last eight quarters, with growth averaging 33.9%.
  • The strongest year-over-year quarter for Total Liabilities in the past five years was the quarter ended Mar 31, 2022, with growth of 303.4%; the weakest was the quarter ended Dec 31, 2025, with a decline of 50.9%.
  • According to Business Quant data, Total Liabilities for the three prior quarters was $1.77 billion (quarter ended Mar 31, 2026), $1.71 billion (quarter ended Dec 31, 2025) and $1.55 billion (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 116.09 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 141.05 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 87.82 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 80.09 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 65.46 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 83.95 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 37.53 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 115.64 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 7.18 Bn
10 Ascendis Pharma A 14.26 Bn 10.50 Bn 362.22 Mn 987.46 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 987.46 Mn
Mar 31, 2026 1.77 Bn
Dec 31, 2025 1.71 Bn
Sep 30, 2025 1.55 Bn
Jun 30, 2025 1.44 Bn
Mar 31, 2025 1.32 Bn
Dec 31, 2024 3.47 Bn
Sep 30, 2024 1.31 Bn
Jun 30, 2024 1.16 Bn
Mar 31, 2024 1.13 Bn
Dec 31, 2023 1.05 Bn
Sep 30, 2023 1.03 Bn
Jun 30, 2023 826.47 Mn
Mar 31, 2023 857.68 Mn
Dec 31, 2022 843.12 Mn
Sep 30, 2022 828.67 Mn
Jun 30, 2022 767.20 Mn
Mar 31, 2022 790.61 Mn
Dec 31, 2021 1.27 Bn
Sep 30, 2021 249.62 Mn
API Access

Ascendis Pharma A Total Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-liabilities&ticker=ASND&period=max&api_key=YOUR_API_KEY